Cambridge Cognition Holdings Plc (LON:COG – Get Free Report)’s stock price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 41.55 ($0.54) and traded as low as GBX 28.06 ($0.36). Cambridge Cognition shares last traded at GBX 28.50 ($0.37), with a volume of 53,821 shares trading hands.
Cambridge Cognition Trading Up 1.8 %
The company has a 50 day moving average price of GBX 36.50 and a 200 day moving average price of GBX 41.55. The company has a debt-to-equity ratio of 92.53, a quick ratio of 0.96 and a current ratio of 0.65. The firm has a market cap of £11.95 million, a price-to-earnings ratio of -712.50 and a beta of 0.72.
Cambridge Cognition Company Profile
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
Featured Articles
- Five stocks we like better than Cambridge Cognition
- Investing in Travel Stocks Benefits
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- Health Care Stocks Explained: Why You Might Want to Invest
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- What is the Shanghai Stock Exchange Composite Index?
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.